Gene Query: CENPA

Dataset Description Geneva Score
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 195.33
scRNASeq analysis of cycling cardiomyocytes 53.85
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 41.76
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 39.59
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 28.82
RNA-seq analysis to identify the genes regulated by p53-SET interplay 21.86
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 21.23
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 20.32
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 19.45
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 18.76
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 17.62
The regulartory role of ZCCHC24 in splicing machinery 16.13
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 15.41
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 14.43
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 14.17
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 14.17
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 13.12
EWSR1 influences alternative splicing through direct and indirect mechanisms 12.15
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 11.91
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 11.59
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.05
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.05
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.62
Characterization of parental and rociletinib-resistant derived H1975 cell lines 10.03
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 9.91
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 9.67
RNAseq Study in CC-671 Treated Cal-51 Cells 9.47
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 9.23
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 9.2
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 9.11
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 9.11
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 8.84
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 8.72
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.69
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.69
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.66
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 8.66
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 8.59
RNA-seq of naive and primed ES cells 8.53
Genome-wide transcriptional response to random aneuploidy in human cells 8.45
Regulation of protein translation during mitosis 8.31
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 8.09
Total RNA-seq in ALL-SIL upon JQ1 inhibition 7.98
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 7.88
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.87
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.84
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 7.81
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 7.81
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.79
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.78
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.75
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.73
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 7.53
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 7.48
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.34
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 7.32
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.29
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.23
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.23
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 7.1
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 7.07
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 7.07
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 7.03
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 6.89
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 6.8
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 6.8
Transcriptional landscape changes during human embryonic stem cell derivation 6.75
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.74
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 6.66
Total RNA-seq in ALL-SIL upon TLX1 knockdown 6.65
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 6.65
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.59
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.45
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 6.35
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 6.33
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.32
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.27
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.27
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 6.12
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 6.12
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.09
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 6.0
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 6.0
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 5.9
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.83
Single-cell analysis of adult human ovary using 10X genomics 5.74
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.56
Transcription control by the ENL YEATS domain in acute leukemia 5.55
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 5.55
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 5.52
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.49
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.49
LIN28A Over-expression RNAseq 5.49
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.45
Effect of drugs on transcriptomic profiles 5.38
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.16
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 5.14
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 5.14
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.13
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.04
Global analysis of enhancer targets: Mosaic-seq 4.95
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.88
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.79
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.79
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 4.77
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.77
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.74
Identification of global regulators of T-helper cell lineage specification 4.73
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 4.73
TGF-β promotes genomic instability after loss of RUNX3 4.72
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.69
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.69
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.69
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.68
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.68
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 4.65
A549 cells and MSR-A549 cells 4.64
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 4.64
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.63
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.62
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.58
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.56
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.49
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.49
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.49
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.47
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 4.47
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.46
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.43
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.43
MYCi361 regulates MYC target genes 4.42
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.4
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.39
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.38
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.38
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.37
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.31
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.19
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 4.18
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 4.18
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.18
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.16
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.16
The landscape of alternative splicing in aggressive prostate cancers 4.14
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 4.14
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.05
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 4.05
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.04
G-quadruplex structures mark human regulatory chromatin 4.03
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 4.03
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.03
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 4.02
m6A-dependent regulation of messenger RNA stability 4.01
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.0
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 3.97
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.96
CROP-Seq in Primary Human T Cells 3.94
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.87
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.87
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.83
Transcriptional profiles of normal human mature B cells 3.83
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.82
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.82
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.82
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.82
Genome-wide analysis of Dengue virus 2 infected cells 3.79
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.77
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.75
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.75
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.74
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.73
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.68
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.68
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.67
Seletive inhibition of CDK9 in DLBCL cell lines 3.65
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.64
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.63
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.63
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 3.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.6
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.6
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.6
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.59
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.59
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.57
Regulation of highly expressed hCINAP on translatome 3.56
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.55
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 3.52
UBC9 knockdown in bladder cancer T24 cell lines 3.52
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 3.51
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 3.51
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.5
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.47
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.47
Effect of Influenza virus infection on lncRNA expression in A549 cells 3.44
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.44
Genome-wide chromatin analysis of Ewing sarcoma 3.43
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.43
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.43
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.41
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 3.38
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.38
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 3.36
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.34
Transcriptional responses of human insulinoma cells to acute cytokine exposure 3.33
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.31
RNA-seq analysis of control and Myc-induced U2OS cells 3.3
AMPK signaling for naïve pluripotency [Hs] 3.29
AMPK signaling for naïve pluripotency 3.29
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.28
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.28
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.28
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.23
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 3.22
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 3.22
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.2
hnRNP C is a key regulator of protein synthesis in mitosis 3.2
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 3.18
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.17
A code of mono-phosphorylation modulates the function of RB. 3.17
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 3.13
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 3.11
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.09
Real-time observation of light-controlled transcription in living cells 3.09
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 3.08
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 3.08
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.04
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 3.02
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.01
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.0
ETV7 and interferon response 3.0
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.0
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.99
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 2.99
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 2.97
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.97
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.97
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.97
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 2.95
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.93
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.93
Neonatal and adult human testis defined at the single-cell level 2.9
Transcriptomic analysis of LSD1 2.9
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.87
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.86
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.85
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.84
PTHrP overexpression in MCF7 cells 2.83
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.82
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.81
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.81
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 2.8
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 2.78
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.78
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.78
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.78
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 2.77
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.76
Gene expression changes upon drug withdrawal (Mel888 cell line) 2.71
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.71
Genetic-to-epigenetic Therapy for Pancreatic Cancer 2.7
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.69
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.69
Effect of CHKA knockdown on C4-2 cell transcriptome 2.68
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 2.67
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.66
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.66
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.66
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.64
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.64
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 2.63
Bone marrow derived human B cells [normal proB] 2.62
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 2.61
RNA-seq of tumor cells following angiopellosis extravasation 2.61
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.6
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.6
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.59
RNA-seq of YB5 cells treated with Proscillaridin A 2.59
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 2.58
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 2.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.58
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.57
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.56
Downregulation of DDX5/DDX17 and REST 2.56
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 2.56
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.55
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.55
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.54
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.53
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.51
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.48
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 2.47
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.45
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 2.45
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.42
Functional role of CPPED1 in trophoblasts. 2.41
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 2.4
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.4
Effect of PRDM11 depletion in U2932 cells 2.37
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.37
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.37
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 2.36
Altering cancer transcriptomes using epigenomic inhibitors 2.36
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 2.36
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 2.36
Transcriptome-wide identification of CELF2 functional targets in T cells 2.35
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.35
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.32
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.31
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.28
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.25
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.23
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.22
Single cell transcriptome of peritoneal cells 2.21
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.19
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.19
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.19
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.17
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.14
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.14
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.13
Paxillin regulates genomic networks in prostate cancer [PC3] 2.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.13
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.09
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.09
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.09
Illumina Total RNA-seq in HeLa 2.08
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.02
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.01
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 2.0
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 2.0
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.0
Identification of HOXB13 target genes responsive to BET inhibitors 1.98
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 1.98
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 1.96
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 1.96
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.94
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 1.93
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.92
IRF2 is a master regulator of human keratinocyte stem cell fate 1.92
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 1.92
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.9
Molecular Criteria for Defining the Naive Human Pluripotent State 1.89
KLF6-dependent transcription in renal cancer cells 1.89
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.88
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.85
Human Treg IL-12 stimulation 1.8
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.8
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.8
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.75
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.74
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.74
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.73
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.71
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.7
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.7
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.68
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.68
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.67
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.66
SLIGRL-induced gene expression changes in NHEK cells 1.63
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.61
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.6
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.6
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.54
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.51
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.5
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.49
snRNAs as regulators of alternative splicing 1.48
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.47
Impact on erythroid progenitor type on erythroid differntiation 1.45
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.45
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.44
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.42
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.4
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.39
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 1.39
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.38
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.37
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.36
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.36
O-glcnAc reprograms cellular energetics 1.36
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.35
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.35
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.35
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.33
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.29
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.27
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.26
Gene expression changes due to PARP knockdown in human cells 1.26
Gene expression of thyroid cancer cell lines 1.23
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.22
TAF1 is critical for AE driven leukemogenesis 1.22
p53 activity results in DNA replication fork processivity 1.21
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.17
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.16
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.14
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.13
RNA-seq analysis of differentiating human erythroblasts 1.11
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.05
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.02
Human Treg NaCl stimulation 1.01
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.0
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.0
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.99
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.98
SF3B1 Degron knockdown RNA-seq 0.96
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.96
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.95
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.92
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 0.91
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.91
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.89
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.89
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.88
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.87
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.86
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.86
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.86
Effect of from Human Umbilical Vein Endothelial Cells 0.86
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.85
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.85
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.84
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.82
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.81
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.79
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.79
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.78
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.74
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.74
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.71
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.64
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.64
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.64
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.64
IMP3 regulated gene expression in breast cancer cells 0.64
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.61
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.6
Single-Cell Genotyping of Transcriptomes 0.6
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.59
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.58
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.57
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.54
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.54
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.54
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.52
RNA editing in nascent RNA affects pre-mRNA splicing 0.52
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.51
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.51
Effect of ILF3 on translation during homeostasis and the antiviral response 0.49
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.48
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.45
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 0.43
6mer seed toxicity in tumour suppressive microRNAs 0.43
Active translatome profiling with RiboLace in MCF7 cells 0.43
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.41
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.4
The cohesin complex prevents Myc-induced replication stress 0.37
Function and hormonal regulation of GATA3 in human first trimester placentation 0.37
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 0.35
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 0.35
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.34
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.33
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.32
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.31
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.3
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.29
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.25
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.24
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.24
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.24
Regulation of poly(A) tail and translation during the somatic cell cycle 0.24
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.23
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.18
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.17
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.16
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.16
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.15
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.13
Myc activation coordinates gene transcription and protein translation responses 0.13
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.12
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.12
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.1
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.07
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.06
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.06
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.02
CDK12 mediated transcriptional regulation in U2OS cells 0.02
The circadian transcriptional landscape in primary human mammary epithelial cells 0.01
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation